AQR Capital Management
GNCA

AQR Capital Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

AQR Capital Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,470
Closed -$146K – 2329
2015
Q4 		$146K Buy
+3,470
New +$165K ﹤0.01% 2190

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AQR Capital Management's GNCA Position: Q1 2016 in Review

AQR Capital Management sold out of Genocea Biosciences, Inc. (GNCA) in Q1 2016, closing a stake of 3,470 shares — an estimated $146K sold.

AQR Capital Management first reported a position in GNCA in Q4 2015 and held it in 1 quarter. The position peaked at $146K in Q4 2015. 59 funds tracked by Wall St. Rank hold GNCA as of Q1 2016.

  • AQR Capital Management reported no remaining Genocea Biosciences, Inc. position as of Q1 2016 after selling out during the quarter.
  • AQR Capital Management sold 3,470 Genocea Biosciences, Inc. shares in Q1 2016, an estimated $146K.
  • AQR Capital Management first reported a position in Genocea Biosciences, Inc. in Q4 2015 and held it in 1 quarter.
  • AQR Capital Management's Genocea Biosciences, Inc. position peaked at $146K in Q4 2015.
  • 59 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2016.

Based on AQR Capital Management's 13F filing for Q1 2016, filed 16 May 2016.